Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002133470 | SCV002450701 | likely benign | Pyridoxine-dependent epilepsy | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002391313 | SCV002698369 | likely benign | Inborn genetic diseases | 2018-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002133470 | SCV004050376 | likely benign | Pyridoxine-dependent epilepsy | 2023-04-11 | criteria provided, single submitter | clinical testing |